Found: 4
Select item for more details and to access through your institution.
Letter: combination of biologics in inflammatory bowel diseases. Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 3, p. 568, doi. 10.1111/apt.15919
- By:
- Publication type:
- Article
Efficacy and safety of simultaneous treatment with two biologic medications in refractory Crohn's disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 51, n. 11, p. 1031, doi. 10.1111/apt.15719
- By:
- Publication type:
- Article
Efficacy of Intravenous Ustekinumab Reinduction in Patients With Crohn's Disease With a Loss of Response.
- Published in:
- Journal of the Canadian Association of Gastroenterology, 2022, v. 5, n. 5, p. 208, doi. 10.1093/jcag/gwac017
- By:
- Publication type:
- Article
Adverse Events and Nocebo Effects in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
- Published in:
- Journal of Crohn's & Colitis, 2019, v. 13, n. 9, p. 1201, doi. 10.1093/ecco-jcc/jjz087
- By:
- Publication type:
- Article